News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Swiss-Italian Biotech, Philogen Eyes up to 65.3 Million Euros in IPO


2/10/2011 8:37:38 AM

ZURICH, Feb 8 (Reuters) - Swiss-Italian biotech group Philogen said it plans to debut on the Milan stock exchange later this month, in Europe's first biotech initial public offering in 2011 and the latest sign appetite for the sector is warming.

Read at Reuters

comments powered by Disqus
Reuters
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES